Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Mivavotinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Tak-659, 1312691-33-0, Tak-659 free base, Mivavotinib [usan], Tak-659f, Tak659
    Molecular Formula
    C17H21FN6O
    Molecular Weight
    344.4  g/mol
    InChI Key
    MJHOMTRKVMKCNE-NWDGAFQWSA-N
    FDA UNII
    8QR88H79VX
    Mivavotinib is an inhibitor of spleen tyrosine kinase (syk), with potential anti-inflammatory, immunomodulating, and antineoplastic activities. Upon administration, mivavotinib may inhibit the activity of syk, which abrogates downstream B-cell receptor (BCR) signaling and leads to an inhibition of B-cell activation, chemotaxis, adhesion and proliferation. Syk, a BCR-associated non-receptor tyrosine kinase that mediates diverse cellular responses, including proliferation, differentiation, and phagocytosis, is expressed in hematopoietic tissues and is often overexpressed in hematopoietic malignancies.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-one
    2.1.2 InChI
    InChI=1S/C17H21FN6O/c1-24-8-9(6-21-24)15-13-10(7-20-17(13)25)14(18)16(23-15)22-12-5-3-2-4-11(12)19/h6,8,11-12H,2-5,7,19H2,1H3,(H,20,25)(H,22,23)/t11-,12+/m0/s1
    2.1.3 InChI Key
    MJHOMTRKVMKCNE-NWDGAFQWSA-N
    2.1.4 Canonical SMILES
    CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)NC4CCCCC4N
    2.1.5 Isomeric SMILES
    CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)N[C@@H]4CCCC[C@@H]4N
    2.2 Other Identifiers
    2.2.1 UNII
    8QR88H79VX
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Tak-659

    2.3.2 Depositor-Supplied Synonyms

    1. Tak-659

    2. 1312691-33-0

    3. Tak-659 Free Base

    4. Mivavotinib [usan]

    5. Tak-659f

    6. Tak659

    7. 8qr88h79vx

    8. Chembl3979920

    9. 6-[[(1r,2s)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-one

    10. 3h-pyrrolo(3,4-c)pyridin-3-one, 6-(((1r,2s)-2-aminocyclohexyl)amino)-7-fluoro-1,2-dihydro-4-(1-methyl-1h-pyrazol-4-yl)-

    11. 3h-pyrrolo[3,4-c]pyridin-3-one, 6-[[(1r,2s)-2-aminocyclohexyl]amino]-7-fluoro-1,2-dihydro-4-(1-methyl-1h-pyrazol-4-yl)-

    12. 6-(((1r,2s)-2-aminocyclohexyl)amino)-7-fluoro-4-(1-methyl-1h-pyrazol-4-yl)-1,2-dihydro-3h-pyrrolo[3,4-c]pyridin-3-one

    13. 6-((1r,2s)-2-aminocyclohexylamino)-7-fluoro-4-(1-methyl-1h-pyrazol-4-yl)-1h-pyrrolo(3,4-c)pyridin-3(2h)-one

    14. 6-((1r,2s)-2-aminocyclohexylamino)-7-fluoro-4-(1-methyl-1h-pyrazol-4-yl)-1h-pyrrolo[3,4-c]pyridin-3(2h)-one

    15. 6-{[(1r,2s)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1h-pyrazol-4-yl)-1,2-dihydro-3h-pyrrolo[3,4-c]pyridin-3-one

    16. Mivavotinib [inn]

    17. Mivavotinib (usan/inn)

    18. Tak659 2hcl

    19. Unii-8qr88h79vx

    20. Mivavotinib [who-dd]

    21. Tak-659 2hcl

    22. Gtpl9600

    23. Schembl1987799

    24. Tak-659 Free Base(mivavotinib)

    25. Bcp28883

    26. Ex-a1401

    27. Bdbm50204290

    28. Cb-659

    29. Nsc791967

    30. Nsc791968

    31. Who 10836

    32. Nsc-791967

    33. Nsc-791968

    34. Compound 3b [pmid: 27839918]

    35. Ac-35463

    36. Hy-100867

    37. Cs-0020533

    38. D11789

    39. 1312691-41-0

    40. Cis-6-(2-aminocyclohexylamino)-7-fluoro-4-(1-methyl-1h-pyrazol-4-yl)-1h-pyrrolo[3,4-c]pyridin-3(2h)-one

    2.4 Create Date
    2011-07-25
    3 Chemical and Physical Properties
    Molecular Weight 344.4 g/mol
    Molecular Formula C17H21FN6O
    XLogP30.5
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count3
    Exact Mass344.17608748 g/mol
    Monoisotopic Mass344.17608748 g/mol
    Topological Polar Surface Area97.9 Ų
    Heavy Atom Count25
    Formal Charge0
    Complexity508
    Isotope Atom Count0
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1